Regulation & Industry

G 1/25: EPO settles controversial patent description question

4 September 2026 Clarity from the Enlarged Board of Appeal for when patent descriptions must be amended to reflect changes to the claims has finally arrived. LSIPR outlines G 1/25, the debate that led to the referral and the EPC provisions at the heart of the ruling.

California votes for law to restrict use of genAI by lawyers

4 September 2026

Teva faces scrutiny over efforts to curb generic competition

27 August 2026

More News

Kirkland clears conflicts hurdle in trade secrets spat

7 August 2026 A federal judge has refused to disqualify Kirkland & Ellis from representing a healthcare tech company after a conflict check came under scrutiny.

Former senior attorney-advisor to ITC commissioners joins Mintz

7 August 2026 After more than 14 years at the US International Trade Commission, the new hire says he was drawn to Mintz for its “continued growth in the life sciences sector”.

Fran Salisbury: ‘There’s nothing quite like finding the missing piece’

5 August 2026 From advising pioneering startups to championing women in the profession, Fran Salisbury of Mewburn Ellis has spent her career making innovation count. Here, she reflects on the challenges, opportunities and motivations that continue to drive her.

Where Big Pharma is betting big in the M&A boom

29 July 2026 Dealmaking is at a record pace, but not every asset is in play. So what are the therapy areas commanding the fiercest bidding wars and what’s to come?

Buying the brains: Why is Big Pharma shopping for innovation?

27 July 2026 With billions in revenue set to disappear as patents expire, pharmaceutical giants are racing to acquire their way out of trouble. But are there other drivers behind the surge—and how long can the momentum last?

Trump slaps 100% tariff on generic drugs in US manufacturing push

23 July 2026 Generic drug manufacturers face huge penalties if they fail to relocate production to the US within two years, with India among the countries expected to be hardest hit.

UK Prime Minister axes science ministry in govt shakeup

22 July 2026 Plans to merge the UK’s standalone science ministry into an expanded business department, coupled with the departure of the Science Minister, mark a change in the country’s approach to science and innovation.

More news

Regulation & Industry

More News

Latest Features

Get up-to-date information on all our publications and events